ROVAMYCINE

This brand name is authorized in Estonia, France, Lithuania, Poland, Romania, Spain, Tunisia, Turkey.

Active ingredients

The drug ROVAMYCINE contains one active pharmaceutical ingredient (API):

1	Spiramycin UNII 71ODY0V87H - SPIRAMYCIN
	Antibacterial antibiotic belonging to the macrolides family. Spiramycin inhibits translocation by binding to bacterial 50S ribosomal subunits with an apparent 1:1 stoichiometry. This antibiotic is a potent inhibitor of the binding to the ribosome of both donor and acceptor substrates. Spiramycin induces rapid breakdown of polyribosomes, an effect which has formerly been interpreted as occurring by normal ribosomal run-off followed by an antibiotic-induced block at or shortly after initiation of a new peptide.
	Read more about Spiramycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA02	Spiramycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1023310, 1028786
ES	Centro de información online de medicamentos de la AEMPS	49735
FR	Base de données publique des médicaments	64212005, 65952065, 67535280
LT	Valstybinė vaistų kontrolės tarnyba	1003150, 1010948
PL	Rejestru Produktów Leczniczych	100058858, 100058870, 100255777
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63533001, W63534001, W63534002
TN	Direction de la Pharmacie et du Médicament	9103531, 9103532
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809018600, 8699809018617